Status:
COMPLETED
Pathophysiology of Gas Exchange and Time Course Changes in Spontaneously Breathing Patients With Acute Respiratory Failure Due to COVID-19. A Multicenter Prospective Study.
Lead Sponsor:
CHU de Reims
Conditions:
Respiratory Insufficiency
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The pathophysiology of SARS-COV-2 related respiratory disease is still poorly understood, especially in its most severe form called acute respiratory distress syndrome (ARDS). In this case, very few s...
Eligibility Criteria
Inclusion
- inclusion criteria :
- Patients with a COVID-19 confirmed infection.
- Admission in intensive care unit for an acute respiratory failure requiring oxygen flow above 6l/min by facial mask.
- Presence of an arterial catheter for blood sampling.
- exclusion criteria :
- Patients on mechanical ventilation on admission to the ICU.
- Patients requiring immediate intubation on admission.
- Patients admitted to the ICU for more than 48 hours at the time of inclusion.
- Pulmonary embolism diagnosed before admission to the ICU.
- Minor patients
- Pregnant women
- Patients under curatorship or guardianship
- Persons deprived of liberty by a judicial or administrative decision
Exclusion
Key Trial Info
Start Date :
June 9 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 15 2023
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT05392062
Start Date
June 9 2021
End Date
April 15 2023
Last Update
December 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Damien JOLLY
Reims, France